Browsing by Author Yang, T.Y.
Showing results 1 to 9 of 9
Issue Date | Title | Author(s) | Text |
---|---|---|---|
- | EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients | Yang, S.Y.; Yang, T.Y.; Chen, K.C.; Li, Y.J.; Hsu, K.H.; Tsai, C.R.; Chen, C.Y.; Hsu, C.P.; Hsia, J.Y.; Chuang, C.Y.; Tsai, Y.H.; Chen, K.Y.; Huang, M.S.; Su, W.C.; Chen, Y.M.; Hsiung, C.A.; Shen, C.Y.; Chang, G.C.; Yang, P.C.; Chen, C.J. | - |
- | Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns | Hsu, K.H.; Chen, K.C.; Yang, T.Y.; Yeh, Y.C.; Chou, T.Y.; Chen, H.Y.; Tsai, C.R.; Chen, C.Y.; Hsu, C.P.; Hsia, J.Y.; Chuang, C.Y.; Tsai, Y.H.; Chen, K.Y.; Huang, M.S.; Su, W.C.; Chen, Y.M.; Hsiung, C.A.; Chang, G.C.; Chen, C.J.; Yang, P.C. | - |
- | Good Response to Gefitinib in a Lung Adenocarcinoma Harboring a Heterozygous Complex Mutation of L833V and H835L in Epidermal Growth Factor Receptor Gene | Yang, T.Y.; Tsai, C.R.; Chen, K.C.; Hsu, K.H.; Lee, H.M.; Chang, G.C. | - |
- | Identification of alpha-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes | Chang, G.C.; Liu, K.J.; Hsieh, C.L.; Hu, T.S.; Charoenfuprasert, S.; Liu, H.K.; Luh, K.T.; Hsu, L.H.; Wu, C.W.; Ting, C.C.; Chen, C.Y.; Chen, K.C.; Yang, T.Y.; Chou, T.Y.; Wang, W.H.; Whang-Peng, J.; Shih, N.Y. | - |
- | Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients | Chang, G.C.; Tsai, C.M.; Chen, K.C.; Yu, C.J.; Shih, J.Y.; Yang, T.Y.; Lin, C.P.; Hsu, J.Y.; Chiu, C.H.; Perng, R.P.; Yang, P.C.; Yang, C.H. | - |
- | Strength and durability of concrete in hot spring environments | Chen, H.J.; 陳豪吉; Yang, T.Y.; Tang, C.W. | - |
- | Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer | Chen, Y.J.; Chang, G.C.; Chen, H.T.; Yang, T.Y.; Kuo, B.I.T.; Hsu, H.C.; Yang, H.W.; Lee, T.S. | - |
- | Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer | Yang, C.H.; Shih, J.Y.; Chen, K.C.; Yu, C.J.; Yang, T.Y.; Lin, C.P.; Su, W.P.; Gow, C.H.; Hsu, C.; Chang, G.C.; Yang, P.C. | - |
- | Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells | Yang, T.Y.; Chang, G.C.; Chen, K.C.; Hung, H.W.; Hsu, K.H.; Sheu, G.T.; Hsu, S.L. | - |